Gold nanoparticles show new way to kill lymphoma without chemotherapy
How do you annihilate lymphoma without using any drugs? Starve it to death by depriving it of what appears to be a favorite food: HDL cholesterol.
Cancer
Jan 21, 2013 |
4.9 / 5 (15) |
1
|
Solving puzzle of B-cell lymphoma development
Germinal centers are sites in the organs of the lymphatic system, formed during the course of an immune response to infection, where B cells intensely proliferate and modify their DNA in order to produce ...
Immunology
Sep 23, 2012 |
4.9 / 5 (7) |
0
|
Study finds how to shutdown cancer's powerful master protein
The powerful master regulatory transcription factor called Bcl6 is key to the survival of a majority of aggressive lymphomas, which arise from the B-cells of the immune system. The protein has long been considered too complex ...
Immunology
Mar 03, 2013 |
5 / 5 (6) |
0
|
A leukemia drug kills cancerous T-cells while sparing normal immunity
Leukemic cutaneous T-cell lymphoma (L-CTCL) is a leukemia arising from T-cells, a type of white blood cell. This cancer can involve the skin and other organs, and patients often die within three years.
Medical research
Jan 25, 2012 |
4.8 / 5 (4) |
0
|
Team demonstrates breakthrough method of stem cell expansion
(Medical Xpress) -- Researchers in the Department of Pathology at Stony Brook University School of Medicine have discovered a laboratory method to expand adult hematopoietic stem cells (HSCs) using the SALL4 ...
Genetics
Jun 07, 2011 |
4.3 / 5 (4) |
0
|
New drug stops aggressive form of childhood leukemia
In a significant breakthrough, investigators at Weill Cornell Medical College and the University of California, San Francisco, have been able to overcome resistance of a form of leukemia to targeted therapy, demonstrating ...
Cancer
May 24, 2011 |
5 / 5 (3) |
0
|
Lymphoma drug shrinks dog tumors, could lead to human treatment
There are many kinds of cancers of the immune system, but one, Activated B-Cell Diffuse Large B-Cell Lymphoma, or ABC-DLBCL, is particularly common and pernicious. Researchers at the University of Pennsylvania’s ...
Cancer
Jul 14, 2011 |
5 / 5 (3) |
0
Scientists look to immune system to handle follicular lymphoma
University of Rochester Medical Center researchers found more evidence that T cells going awry in the microenvironment – or the tissue immediately surrounding the tumor – may play a role in the biology ...
Cancer
Oct 12, 2011 |
5 / 5 (3) |
0
|
New potential therapeutic target identified for Diffuse Large B-Cell Lymphoma
Researchers from the NYU Cancer Institute, an NCI-designated cancer center at NYU Langone Medical Center, have discovered a new potential therapeutic target for Diffuse Large B-Cell Lymphoma (DLBCL), the most aggressive and ...
Cancer
Nov 28, 2011 |
5 / 5 (3) |
0
|
New compound targets key mechanism behind lymphoma
Scientists at Fox Chase Cancer Center in Philadelphia have come one step closer to developing the first treatment to target a key pathway in lymphoma. The new findings will be announced at the AACR Annual Meeting 2012 on ...
Cancer
Apr 03, 2012 |
5 / 5 (3) |
0
New pill holds promise for fewer side effects in treating leukemia
(Medical Xpress)—An international team of researchers has developed a new anti-cancer drug that holds promise as a therapy that fights cancer while causing fewer side effects than current medicines. The ...
Cancer
Jan 07, 2013 |
5 / 5 (3) |
0
|
Team finds general mechanism that accelerates tumor development
ICREA professor Raúl Méndez publishes a study in Nature describing how the CPBE1 protein "takes the brakes off" the production of proteins associated with the cell switch from being healthy to tumorous. ...
Cancer
Feb 24, 2013 |
5 / 5 (3) |
0
Researchers discover master regulator that drives majority of lymphoma
A soon-to-be-tested class of drug inhibitors were predicted to help a limited number of patients with B-cell lymphomas with mutations affecting the EZH2 protein. However, a research team, led by investigators at Weill Cornell ...
Cancer
May 13, 2013 |
5 / 5 (3) |
0
|
Researchers discover possible drug targets for common non-Hodgkin's lymphoma
Researchers at the University of Maryland School of Medicine have discovered a novel interaction between two proteins involved in regulating cell growth that could provide possible new drug targets for treating diffuse large ...
Cancer
Jul 19, 2011 |
5 / 5 (2) |
0
|
Researchers identify genetic mutation responsible for most cases of Waldenstrom's macroglobulinemia
Scientists at Dana-Farber Cancer Institute have identified a gene mutation that underlies the vast majority of cases of Waldenstrom's macroglobulinemia, a rare form of lymphoma that has eluded all previous ...
Cancer
Dec 12, 2011 |
5 / 5 (2) |
0
